Dr. Sznol Discusses Advancements in Immunotherapy for RCC – OncLive
|
Dr. Sznol Discusses Advancements in Immunotherapy for RCC
OncLive Mario Sznol, MD, professor of medicine, co-director, Yale SPORE in Skin Cancer, Yale Cancer Center, discusses advancements in immunotherapy for the treatment of patients with renal cell carcinoma (RCC). One of the biggest advancements in the treatment … |
